Resistance to the growth-inhibitory action of retinoic acid (RA), the bioactive derivative of vitamin A, is common in human tumors. One form of RA resistance has been associated with silencing and hypermethylation of the retinoic acid receptor 2 gene (RAR2), an RA-regulated tumor suppressor gene. The presence of an epigenetically silent RAR2 correlates with lack of the RA receptor ␣ (RAR␣). Normally, RAR␣ regulates RAR2 transcription by mediating dynamic changes of RAR2 chromatin in the presence and absence of RA. Here we show that interfering with RA signal through RAR␣ (which was achieved by use of a dominantnegative RAR␣, by downregulation of RAR␣ by RNA interference, and by use of RAR␣ antagonists) induces an exacerbation of the repressed chromatin status of RAR2 and leads to RAR2 transcriptional silencing. Further, we demonstrate that RAR2 silencing causes resistance to the growth-inhibitory effect of RA. Apparently, RAR2 silencing can also occur in the absence of DNA methylation. Conversely, we demonstrate that restoration of RA signal at a silent RAR2 through RAR␣ leads to RAR2 reactivation. This report provides proof of principle that RAR2 silencing and RA resistance are consequent to an impaired integration of RA signal at RAR2 chromatin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.